Maykin Ho is a prominent figure in the healthcare investment and pharmaceutical industries, serving as a Board Director at Agios, BioMarin, Fibrogen, Neumora, and Parexel. Currently a Venture Partner at Qiming, Maykin was a retired partner and Advisory Director at Goldman Sachs, where they focused on healthcare investment banking in China and the U.S. Additionally, Maykin has held various leadership roles at DuPont and has extensive experience in biotechnology research. They earned a postdoctoral fellowship in Immunology from Harvard Medical School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices